Tag: #Global Trends

Pharmaceutical giant Merck has announced a multi-target research and development collaboration with biotechnology startup Infinimmune. The deal, potentially worth up... Read more

The U.S. Food and Drug Administration (FDA) has issued a significant safety communication regarding Tavneos, a specialty drug for rare... Read more

Merck & Co.’s $6.7 billion acquisition offer for Terns Pharmaceuticals has ignited a wave of debate across Wall Street. The... Read more

The Cuban healthcare sector is navigating an unprecedented period of hardship due to the combined impact of an energy crisis... Read more

Researchers at Peking University, led by Professor Jiao Ning, have unveiled a novel chemical method to elevate the value of... Read more

Sarepta Therapeutics saw its stock jump 25% on Wednesday, March 25, 2026, following the release of encouraging Phase 1/2 clinical... Read more

On March 23, 2026, Gilead Sciences announced a definitive agreement to acquire Ouro Medicines in a deal potentially worth $2.175... Read more

On March 24, 2026, Bayer’s stock experienced a brief decline following a significant divestment by Inclusive Capital Partners. The move... Read more

On March 25, 2026, Japan’s largest pharmaceutical company, Takeda, unveiled a sweeping new restructuring initiative. The program aims to deliver... Read more